Home/Filings/4/0000899243-21-022345

4//SEC Filing

LEVIN MARK J 4

Accession 0000899243-21-022345

CIK 0001628171other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 6:10 PM ET

Size

21.4 KB

Accession

0000899243-21-022345

Insider Transaction Report

Form 4

Period: 2021-06-03

Revolution Medicines, Inc.RVMD

Third Rock Ventures GP II, L.P.

10% Owner

Transactions

Sale
Common Stock
2021-06-03$30.20/sh−378,117$11,419,133→ 164,996 total
Sale
Common Stock
2021-06-04$30.23/sh−164,996$4,987,829→ 0 total

Holdings

Common Stock
(indirect: See footnote)
0
Common Stock
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
129,256
Common Stock
(indirect: See footnote)
5,524,031
Common Stock
129,258

Third Rock Ventures II, L.P.

10% Owner

Transactions

Sale
Common Stock
2021-06-03$30.20/sh−378,117$11,419,133→ 164,996 total
Sale
Common Stock
2021-06-04$30.23/sh−164,996$4,987,829→ 0 total

Holdings

Common Stock
(indirect: See footnote)
0
Common Stock
129,258
Common Stock
(indirect: See footnote)
5,524,031
Common Stock
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
129,256

TRV GP II, LLC

10% Owner

Transactions

Sale
Common Stock
2021-06-04$30.23/sh−164,996$4,987,829→ 0 total
Sale
Common Stock
2021-06-03$30.20/sh−378,117$11,419,133→ 164,996 total

Holdings

Common Stock
129,256
Common Stock
129,258
Common Stock
(indirect: See footnote)
5,524,031
Common Stock
(indirect: See footnote)
0
Common Stock
116,334
Common Stock
(indirect: See footnote)
12,925

STARR KEVIN P

10% Owner

Transactions

Sale
Common Stock
2021-06-04$30.23/sh−164,996$4,987,829→ 0 total
Sale
Common Stock
2021-06-03$30.20/sh−378,117$11,419,133→ 164,996 total

Holdings

Common Stock
(indirect: See footnote)
12,925
Common Stock
129,258
Common Stock
(indirect: See footnote)
5,524,031
Common Stock
129,256
Common Stock
(indirect: See footnote)
0
Common Stock
116,334

TEPPER ROBERT I

10% Owner

Transactions

Sale
Common Stock
2021-06-03$30.20/sh−378,117$11,419,133→ 164,996 total
Sale
Common Stock
2021-06-04$30.23/sh−164,996$4,987,829→ 0 total

Holdings

Common Stock
(indirect: See footnote)
0
Common Stock
116,334
Common Stock
(indirect: See footnote)
12,925
Common Stock
129,258
Common Stock
(indirect: See footnote)
5,524,031
Common Stock
129,256

LEVIN MARK J

10% Owner

Transactions

Sale
Common Stock
2021-06-03$30.20/sh−378,117$11,419,133→ 164,996 total
Sale
Common Stock
2021-06-04$30.23/sh−164,996$4,987,829→ 0 total

Holdings

Common Stock
116,334
Common Stock
129,258
Common Stock
(indirect: See footnote)
5,524,031
Common Stock
(indirect: See footnote)
0
Common Stock
(indirect: See footnote)
12,925
Common Stock
129,256

Footnotes (9)

[F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
[F2]These shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II"). The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
[F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $30.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
[F4]These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Levin, Starr and Tepper. Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
[F5]Third Rock Ventures IV, L.P. ("TRV IV") directly holds 1,419,900 shares of Common Stock of the Issuer. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of the reporting persons and TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
[F6]The shares are directly held by Levin.
[F7]The shares are directly held by Levin Family 2014 Irrevocable Trust.
[F8]The shares are directly held by Starr.
[F9]The shares are directly held by Tepper.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Revolution Medicines, Inc.

CIK 0001628171

→

Entity typeother

Related Parties

filerCIK 0001180428

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 6:10 PM ET
Size: 21.4 KB

View on SEC.gov